Pascolutti, R.; Yeturu, L.; Philippin, G.; Costa Borges, S.; Dejob, M.; Santiago-Raber, M.-L.; Derouazi, M.
ATP128 Clinical Therapeutic Cancer Vaccine Activates NF-κB and IRF3 Pathways through TLR4 and TLR2 in Human Monocytes and Dendritic Cells. Cancers 2022, 14, 5134.
https://doi.org/10.3390/cancers14205134
AMA Style
Pascolutti R, Yeturu L, Philippin G, Costa Borges S, Dejob M, Santiago-Raber M-L, Derouazi M.
ATP128 Clinical Therapeutic Cancer Vaccine Activates NF-κB and IRF3 Pathways through TLR4 and TLR2 in Human Monocytes and Dendritic Cells. Cancers. 2022; 14(20):5134.
https://doi.org/10.3390/cancers14205134
Chicago/Turabian Style
Pascolutti, Roberta, Lakshmi Yeturu, Géraldine Philippin, Stéphane Costa Borges, Magali Dejob, Marie-Laure Santiago-Raber, and Madiha Derouazi.
2022. "ATP128 Clinical Therapeutic Cancer Vaccine Activates NF-κB and IRF3 Pathways through TLR4 and TLR2 in Human Monocytes and Dendritic Cells" Cancers 14, no. 20: 5134.
https://doi.org/10.3390/cancers14205134
APA Style
Pascolutti, R., Yeturu, L., Philippin, G., Costa Borges, S., Dejob, M., Santiago-Raber, M.-L., & Derouazi, M.
(2022). ATP128 Clinical Therapeutic Cancer Vaccine Activates NF-κB and IRF3 Pathways through TLR4 and TLR2 in Human Monocytes and Dendritic Cells. Cancers, 14(20), 5134.
https://doi.org/10.3390/cancers14205134